• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $PATH

    UiPath Inc.

    Subscribe to $PATH
    $PATH
    Computer Software: Prepackaged Software
    Technology

    UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows. The company also offers UiPath Robots, which emulates human behavior to execute the processes built in UiPath Studio; and UiPath Orchestrator that tracks and logs robot activity, along with what people do in tandem to maintain strict compliance and governance through dashboards and visualization tools. In addition, it provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

    IPO Year: 2021

    Exchange: NYSE

    Website: uipath.com

    Peers

    $APPN
    $PEGA
    $NOW

    Recent Analyst Ratings for UiPath Inc.

    DatePrice TargetRatingAnalyst
    3/13/2025$10.00Neutral → Underperform
    BofA Securities
    12/12/2024Sell
    UBS
    6/3/2024$29.00 → $12.00Outperform → Neutral
    Macquarie
    5/30/2024Buy → Hold
    Needham
    5/30/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    5/30/2024$28.00 → $17.00Buy → Hold
    TD Cowen
    5/30/2024Outperform → Mkt Perform
    William Blair
    5/30/2024$32.00 → $14.00Buy → Hold
    Truist
    5/30/2024$30.00 → $16.00Buy → Neutral
    BofA Securities
    4/8/2024$27.00Overweight
    KeyBanc Capital Markets
    See more ratings